Shattuck Labs Revenue and Competitors

Austin, TX USA

Location

$175M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Shattuck Labs's estimated annual revenue is currently $1.3M per year.(i)
  • Shattuck Labs's estimated revenue per employee is $14,222
  • Shattuck Labs's total funding is $175M.
  • Shattuck Labs's current valuation is $308.4M. (January 2022)

Employee Data

  • Shattuck Labs has 90 Employees.(i)
  • Shattuck Labs grew their employee count by -10% last year.

Shattuck Labs's People

NameTitleEmail/Phone
1
CEO and Co-founderReveal Email/Phone
2
Sr VPReveal Email/Phone
3
VP Translational MedicineReveal Email/Phone
4
SVP, QualityReveal Email/Phone
5
VP BiometricsReveal Email/Phone
6
General Counsel, Corporate Secretary, and Chief Ethics and Compliance OfficerReveal Email/Phone
7
VP Investor RelationsReveal Email/Phone
8
VP Research & DevelopmentReveal Email/Phone
9
VP, Clinical OperationsReveal Email/Phone
10
Head Portfolio Management, Tech OpsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Shattuck Labs?

Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARCᅢᄁ¬ダᅡᄁ) platform to develop a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and inflammatory diseases. Using its ARCᅢᄁ¬ダᅡᄁ platform, Shattuck is building a pipeline of therapeutics, that consolidate checkpoint blockade and TNF receptor agonists into single therapeutics to improve outcomes for patients. Shattuck has offices in Austin, Texas and Durham, North Carolina.

keywords:N/A

$175M

Total Funding

90

Number of Employees

$1.3M

Revenue (est)

-10%

Employee Growth %

$308.4M

Valuation

N/A

Accelerator

Shattuck Labs News

2022-04-19 - Vallon, Shattuck Labs top healthcare gainers; Babylon, SCYNEXIS lead losers' pack

Vallon, Shattuck Labs top healthcare gainers; Babylon, SCYNEXIS lead losers' pack. Apr. 22, 2022 10:04 AM ETHCA, SCYX, VLON, STTK, ESTA, INVO, NOVN, BBLN,...

2022-04-06 - Shattuck Labs Announces Participation in Upcoming 21st ...

About Shattuck Labs, Inc. Shattuck Labs, Inc. (NASDAQ: STTK) is a clinical-stage biotechnology company pioneering the development of bi-...

2022-04-06 - Shattuck Labs Presents Preclinical Data at the 2022 American ...

AUSTIN, TX and DURHAM, NC, April 08, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology...

2020-06-15 - Austin biotech startup Shattuck Labs raises $118M to fight cancer

Shattuck Labs, a biotech startup co-located in Austin and Durham, N.C., has raised a $118 million Series B investment to continue developing cancer-fighting treatments, the company announced Monday. San Francisco-based health care investment firm Redmile Group led the round. The company had pre ...

2020-06-15 - Shattuck Labs Closes $118M Series B Financing

Shattuck Labs, Inc., a Durham, North Carolina and Austin, Texas-based clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC™) platform to develop a novel class of biologic medicines for the treatment of cancer and autoimmune disease, closed a $118m Ser ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.6M906%N/A
#2
$14.7M902%N/A
#3
$11.7M90N/AN/A
#4
$14M90-18%N/A
#5
$24.3M903%N/A